◀ Back to CD8A

CD8A — GP6

Text-mined interactions from Literome

Gorse et al., AIDS Res Hum Retroviruses 2001 (HIV Infections) : There was a possible association between HIV-1 envelope glycoprotein stimulated interleukin 2 secretion and CD8 ( + ) CTLs against HIV-1 envelope glycoprotein, and an inverse relation between lymphocyte proliferation and CTLs against HIV-1 Gag antigens
Campbell et al., Clin Immunol 2002 (Carcinoma, Hepatocellular...) : A 180-kDa glycoprotein ( gp180 ) has been identified and shown to be important in CD8 ( + ) T cell activation by intestinal epithelial cells
Gorse et al., Clinical and vaccine immunology : CVI 2006 (HIV Infections) : Mean frequencies of HIV-1 envelope glycoprotein stimulated , activated intra-cellular IFN-gamma producing CD4 ( + ) and CD8 ( + ) lymphocytes and of interleukin-2 producing CD4 ( + ) lymphocytes did not increase after vaccination, but cytokine producing cells were detectable in some patients
Kim et al., Clin Immunol Immunopathol 1991 (Autoimmune Diseases) : It has been shown previously that there is a strong correlation between the in vitro release of soluble CD8 glycoprotein ( sCD8 ) and CD8+ T lymphocyte activation
Mallick et al., PloS one 2013 (Sarcoma, Experimental) : Neem leaf glycoprotein activates CD8 ( + ) T cells to promote therapeutic anti-tumor immunity inhibiting the growth of mouse sarcoma
Toy et al., J Clin Invest 1997 (Colitis, Ulcerative...) : A 180-kD glycoprotein ( gp180 ) recognized by mAbs B9 and L12 has been identified and shown to be important in CD8+ T cell activation by IEC